Building the marketplace for generic medicines is a key strategy to containing drug costs in the US, one that USP actively supports through our standards-setting work.
Update: Read more about the panel discussion on Scientific American: An Overlooked Too
Amid the backdrop of the 72nd United Nations General Assembly (UNGA), USP introduced its Quality Institute – a center that will conduct much-needed research to foster evidence-based policy decisions that can help increase the availabil
USP and the Asia Pacific Economic Cooperation (APEC) partners are exploring new ways to stem the tide of substandard and falsified medicines. Read more.